396-P: The Humanistic Burden of Type 1 Diabetes in U.S. Adults With or Without Recurrent Severe Hypoglycemic Events—A Qualitative Interview Study
Introduction: Despite advances in technology, many people with type 1 diabetes (T1D) still experience severe hypoglycemic events (SHEs). This study explored the perceived humanistic burden of T1D in adults using continuous glucose monitor (CGM) in the US with or without recurrent SHEs. Methods: In 6...
Saved in:
Published in | Diabetes (New York, N.Y.) Vol. 72; no. Supplement_1; p. 1 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
American Diabetes Association
20.06.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Introduction: Despite advances in technology, many people with type 1 diabetes (T1D) still experience severe hypoglycemic events (SHEs). This study explored the perceived humanistic burden of T1D in adults using continuous glucose monitor (CGM) in the US with or without recurrent SHEs.
Methods: In 60-minute semi-structured interviews, adult CGM users with self-reported T1D diagnosis (≥5 yrs.) described the burden of TID on quality of life (QoL). Participants ranked the ‘top 3’ negative impacts of T1D on QoL. Subgroup analyses were conducted in participants with recurrent SHE (rSHE; ≥2 SHEs last yr.) and without recurrent SHE (nSHE; ≤1 SHEs last yr.).
Results: Participants (N=31; 42% rSHEs, 58% nSHEs) were 74% female and 81% were married. Mean age of T1D diagnosis was 28 yrs. Median SHEs in the past year in the rSHE group were 3 and in the nSHE group were 0. Both groups had mean HbA1c of 7.1%. rSHE and nSHE participants used hybrid closed loop systems (hCLS) (53.8% vs. 44.4%), multiple daily injections (23.1% vs. 33.3%) and continuous subcutaneous insulin infusion pump without hCLS (23.1% vs. 22.2%), respectively. All participants reported negative impacts on physical health, mental health, sleep, relationships, leisure activities, work/studies, and sex life. The ‘top 3’ ranked impacts for the rSHE cohort were physical health and sleep (tied at first) followed by leisure activities. Impacts to physical health, mental health, and relationships were ‘top 3’ for the nSHE cohort.
Conclusions: Recurrent severe hypoglycemia is observed to persist despite use of advanced diabetes technology. Negative impacts on physical health ranked as the primary concern in both rSHE and nSHE cohorts. However, moderate variability in ranked negative impact order was observed between the cohorts.
Disclosure
A.Boateng-kuffour: None. P.Callahan: Consultant; Rhythm Pharmaceuticals, Inc., Abbott Diabetes, HealthCore Inc., BMS, Employee; Vertex Pharmaceuticals Incorporated, Genesis Research. K.Chandarana: Employee; Vertex Pharmaceuticals Incorporated, Stock/Shareholder; Vertex Pharmaceuticals Incorporated. J.L.Gaglia: Advisory Panel; Dompé, Consultant; Vertex Pharmaceuticals Incorporated, Abata Therapeutics, Avotres Inc., Current Health, Research Support; Avotres Inc., Dompé, Imcyse, Stock/Shareholder; Vertex Pharmaceuticals Incorporated. M.Phinney: None. E.Guzman ortega: Research Support; Vertex Pharmaceuticals Incorporated. R.N.Krupnick: Consultant; Vertex Pharmaceuticals Incorporated. M.Reaney: None. W.H.Polonsky: Consultant; Abbott Diabetes, Boehringer Ingelheim and Eli Lilly Alliance, Eli Lilly and Company, Insulet Corporation, Intuity Medical, Inc., MannKind Corporation, Provention Bio, Inc., Sanofi-Aventis U.S., Vertex Pharmaceuticals Incorporated. |
---|---|
AbstractList | Introduction: Despite advances in technology, many people with type 1 diabetes (T1D) still experience severe hypoglycemic events (SHEs). This study explored the perceived humanistic burden of T1D in adults using continuous glucose monitor (CGM) in the US with or without recurrent SHEs. Methods: In 60-minute semi-structured interviews, adult CGM users with self-reported T1D diagnosis (≥5 yrs.) described the burden of TID on quality of life (QoL). Participants ranked the 'top 3' negative impacts of T1D on QoL. Subgroup analyses were conducted in participants with recurrent SHE (rSHE; ≥2 SHEs last yr.) and without recurrent SHE (nSHE; ≤1 SHEs last yr.). Results: Participants (N=31; 42% rSHEs, 58% nSHEs) were 74% female and 81% were married. Mean age of T1D diagnosis was 28 yrs. Median SHEs in the past year in the rSHE group were 3 and in the nSHE group were 0. Both groups had mean HbA1c of 7.1%. rSHE and nSHE participants used hybrid closed loop systems (hCLS) (53.8% vs. 44.4%), multiple daily injections (23.1% vs. 33.3%) and continuous subcutaneous insulin infusion pump without hCLS (23.1% vs. 22.2%), respectively. All participants reported negative impacts on physical health, mental health, sleep, relationships, leisure activities, work/studies, and sex life. The 'top 3' ranked impacts for the rSHE cohort were physical health and sleep (tied at first) followed by leisure activities. Impacts to physical health, mental health, and relationships were 'top 3' for the nSHE cohort. Conclusions: Recurrent severe hypoglycemia is observed to persist despite use of advanced diabetes technology. Negative impacts on physical health ranked as the primary concern in both rSHE and nSHE cohorts. However, moderate variability in ranked negative impact order was observed between the cohorts. Introduction: Despite advances in technology, many people with type 1 diabetes (T1D) still experience severe hypoglycemic events (SHEs). This study explored the perceived humanistic burden of T1D in adults using continuous glucose monitor (CGM) in the US with or without recurrent SHEs. Methods: In 60-minute semi-structured interviews, adult CGM users with self-reported T1D diagnosis (≥5 yrs.) described the burden of TID on quality of life (QoL). Participants ranked the ‘top 3’ negative impacts of T1D on QoL. Subgroup analyses were conducted in participants with recurrent SHE (rSHE; ≥2 SHEs last yr.) and without recurrent SHE (nSHE; ≤1 SHEs last yr.). Results: Participants (N=31; 42% rSHEs, 58% nSHEs) were 74% female and 81% were married. Mean age of T1D diagnosis was 28 yrs. Median SHEs in the past year in the rSHE group were 3 and in the nSHE group were 0. Both groups had mean HbA1c of 7.1%. rSHE and nSHE participants used hybrid closed loop systems (hCLS) (53.8% vs. 44.4%), multiple daily injections (23.1% vs. 33.3%) and continuous subcutaneous insulin infusion pump without hCLS (23.1% vs. 22.2%), respectively. All participants reported negative impacts on physical health, mental health, sleep, relationships, leisure activities, work/studies, and sex life. The ‘top 3’ ranked impacts for the rSHE cohort were physical health and sleep (tied at first) followed by leisure activities. Impacts to physical health, mental health, and relationships were ‘top 3’ for the nSHE cohort. Conclusions: Recurrent severe hypoglycemia is observed to persist despite use of advanced diabetes technology. Negative impacts on physical health ranked as the primary concern in both rSHE and nSHE cohorts. However, moderate variability in ranked negative impact order was observed between the cohorts. Disclosure A.Boateng-kuffour: None. P.Callahan: Consultant; Rhythm Pharmaceuticals, Inc., Abbott Diabetes, HealthCore Inc., BMS, Employee; Vertex Pharmaceuticals Incorporated, Genesis Research. K.Chandarana: Employee; Vertex Pharmaceuticals Incorporated, Stock/Shareholder; Vertex Pharmaceuticals Incorporated. J.L.Gaglia: Advisory Panel; Dompé, Consultant; Vertex Pharmaceuticals Incorporated, Abata Therapeutics, Avotres Inc., Current Health, Research Support; Avotres Inc., Dompé, Imcyse, Stock/Shareholder; Vertex Pharmaceuticals Incorporated. M.Phinney: None. E.Guzman ortega: Research Support; Vertex Pharmaceuticals Incorporated. R.N.Krupnick: Consultant; Vertex Pharmaceuticals Incorporated. M.Reaney: None. W.H.Polonsky: Consultant; Abbott Diabetes, Boehringer Ingelheim and Eli Lilly Alliance, Eli Lilly and Company, Insulet Corporation, Intuity Medical, Inc., MannKind Corporation, Provention Bio, Inc., Sanofi-Aventis U.S., Vertex Pharmaceuticals Incorporated. |
Author | PHINNEY, MICHAEL REANEY, MATTHEW GUZMAN ORTEGA, ERICK GAGLIA, JASON L. BOATENG-KUFFOUR, ADRIANA CHANDARANA, KEVAL KRUPNICK, ROBERT N. POLONSKY, WILLIAM H. CALLAHAN, PATRICK |
Author_xml | – sequence: 1 givenname: ADRIANA surname: BOATENG-KUFFOUR fullname: BOATENG-KUFFOUR, ADRIANA – sequence: 2 givenname: PATRICK surname: CALLAHAN fullname: CALLAHAN, PATRICK – sequence: 3 givenname: KEVAL surname: CHANDARANA fullname: CHANDARANA, KEVAL – sequence: 4 givenname: JASON L. surname: GAGLIA fullname: GAGLIA, JASON L. – sequence: 5 givenname: MICHAEL surname: PHINNEY fullname: PHINNEY, MICHAEL – sequence: 6 givenname: ERICK surname: GUZMAN ORTEGA fullname: GUZMAN ORTEGA, ERICK – sequence: 7 givenname: ROBERT N. surname: KRUPNICK fullname: KRUPNICK, ROBERT N. – sequence: 8 givenname: MATTHEW surname: REANEY fullname: REANEY, MATTHEW – sequence: 9 givenname: WILLIAM H. surname: POLONSKY fullname: POLONSKY, WILLIAM H. |
BookMark | eNotkElOw0AQRVsIJMKw4QQlsUNy6MF2p9kFCIOExJAg2Fl2uxoaJXboIcg77gAn5CSYQbX4i3p6pfpbZL1pGyRkj9EhF0Ie1hUXiVB5crNGBkwJlQguH9fJgFLGEyaV3CRb3r9QSvN-BuTjFz6C2TPCRVyUjfXBajiOrsYGWgOzbonA4NSWFQb0YBu4H06HMK7jPHh4sOEZWvebbQxwhzo6h02AKa7Q9dJu2T7NO42LXjtZ9Rv_9f45httYzm0og10hXDYB3criG0xDrLsdsmHKucfd_9wms7PJ7OQiubo-vzwZXyU67x8bSZ5WjI9olqeGG51LipVBoVNNucykqUxtmMioEmJUZlooWjKtea4FspRWYpvs_2mXrn2N6EPx0kbX9BcLPkqVyFQmVU8d_FHatd47NMXS2UXpuoLR4qfz4qfzoq-xuBHfHqx2xg |
ContentType | Journal Article |
Copyright | Copyright American Diabetes Association Jun 2023 |
Copyright_xml | – notice: Copyright American Diabetes Association Jun 2023 |
DBID | AAYXX CITATION K9. NAPCQ |
DOI | 10.2337/db23-396-P |
DatabaseName | CrossRef ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium |
DatabaseTitle | CrossRef ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium |
DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1939-327X |
ExternalDocumentID | 10_2337_db23_396_P |
Genre | Conference Proceeding |
GeographicLocations | United States--US |
GeographicLocations_xml | – name: United States--US |
GroupedDBID | --- .55 .XZ 08P 0R~ 18M 29F 2WC 354 4.4 53G 5GY 5RE 5RS 5VS 6PF 8R4 8R5 AAQQT AAWTL AAYEP AAYXX ABOCM ACGFO ACGOD ACPRK ADBBV AEGXH AENEX AERZD AFHIN AHMBA AIAGR AIZAD ALIPV ALMA_UNASSIGNED_HOLDINGS BAWUL BES BTFSW CITATION CS3 DIK DU5 E3Z EBS EDB EMOBN EX3 F5P FRP GX1 HZ~ IAO IEA IHR INH INR IOF IPO K2M KQ8 L7B M5~ O5R O5S O9- OHH OK1 OVD P2P PCD Q2X RHF RHI RPM SJN SV3 TDI TEORI TR2 VVN W8F WH7 WOQ WOW X7M YFH YHG YOC ZY1 ~KM K9. NAPCQ |
ID | FETCH-LOGICAL-c639-8724b1280564f2fc670ebfe3c4c02757fbfdf13509338a5c390a1cc26c3e140b3 |
ISSN | 0012-1797 |
IngestDate | Fri Sep 13 07:52:20 EDT 2024 Fri Aug 23 01:06:31 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | Supplement_1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c639-8724b1280564f2fc670ebfe3c4c02757fbfdf13509338a5c390a1cc26c3e140b3 |
PQID | 2849359579 |
PQPubID | 34443 |
ParticipantIDs | proquest_journals_2849359579 crossref_primary_10_2337_db23_396_P |
PublicationCentury | 2000 |
PublicationDate | 2023-06-20 |
PublicationDateYYYYMMDD | 2023-06-20 |
PublicationDate_xml | – month: 06 year: 2023 text: 2023-06-20 day: 20 |
PublicationDecade | 2020 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York |
PublicationTitle | Diabetes (New York, N.Y.) |
PublicationYear | 2023 |
Publisher | American Diabetes Association |
Publisher_xml | – name: American Diabetes Association |
SSID | ssj0006060 |
Score | 2.473738 |
Snippet | Introduction: Despite advances in technology, many people with type 1 diabetes (T1D) still experience severe hypoglycemic events (SHEs). This study explored... |
SourceID | proquest crossref |
SourceType | Aggregation Database |
StartPage | 1 |
SubjectTerms | Diabetes Diabetes mellitus (insulin dependent) Diagnosis Hypoglycemia Mental health Quality of life Sleep |
Title | 396-P: The Humanistic Burden of Type 1 Diabetes in U.S. Adults With or Without Recurrent Severe Hypoglycemic Events—A Qualitative Interview Study |
URI | https://www.proquest.com/docview/2849359579/abstract/ |
Volume | 72 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEF7cFEovpU-aNi0D7U3ItbSS1-rNrRPc5oHBDvgmdldaJxDkkNiH9F_0__THdWZ39UgIpe1FNmtY5JlPOw99M8PYR5WkhSZaRSZVgQGK4GFm8HEvjNA6lSMhCqp3Pj4ZTk-T78t02ev96rCWthvV1z_urSv5H63iGuqVqmT_QbPNpriA31G_eEUN4_WvdMyzYTireRM2HW_bLgeuNoH8QAozgyiY1BnW8yo47c_7wZjabhD3dXNGjHT6dARl7fs1zUuUBm56c7leXdxoS6HfJ27kdTgOXOMN1zLcphRt-cu86VTrnd1JJ697d-JPJwPxZY3-brUKD7fG4L-2p1WB0qtaEhFl-89cqtbNFGjqi6g6opBocF1pGzUvbyhFctVQgWnO4lE3wxHTtIkwHrSYrF9dNXd9F7n-bI9iarbqzHfpjvOMZyGPxbJ73rtRQf7Aju4zIzG3jQgKhfdiNdkay5ogMB3P89nkID_6dnL4gD2MRZaKOlfk_QAMDV0BlL8v1xyX9v7U7nzbHbrtDVgXZ_GUPfGxCYwd0J6xXlk9Z4-OPfviBftp9_oMiDZo0QYObbA2QGiDCGoJwnkFhDZwaANCGayvwKMNGrSBQxt00QY12qCDNmjQBhZtL9niYH_xdRr6kR6hRlcYTW-cKPSI0OtOTGz0UAxKZUquE02vz4VRpjARTynNNpKp5tlARlrHQ83LKBko_ortVOuqfM0gSXCljGTBU5WM5FAaSbZmhBG2EErLXfahFmx-6Rq35BjwkvhzEn-OIstnu2yvlnnuH-zrHD02W68usjd__vkte9zidY_tbK625Tv0UTfqvYXCbyjqlEw |
link.rule.ids | 315,786,790,27957,27958 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=396-P%3A+The+Humanistic+Burden+of+Type+1+Diabetes+in+U.S.+Adults+With+or+Without+Recurrent+Severe+Hypoglycemic+Events-A+Qualitative+Interview+Study&rft.jtitle=Diabetes+%28New+York%2C+N.Y.%29&rft.au=Boateng-Kuffour%2C+Adriana&rft.au=Callahan%2C+Patrick&rft.au=Chandarana%2C+Keval&rft.au=Gaglia%2C+Jason+L&rft.date=2023-06-20&rft.pub=American+Diabetes+Association&rft.issn=0012-1797&rft.eissn=1939-327X&rft.volume=72&rft.spage=1&rft_id=info:doi/10.2337%2Fdb23-396-P&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-1797&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-1797&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-1797&client=summon |